SAB BIO logo

SAB BIO

Working to transform treatment for people living with type 1 diabetes through a unique disease-modifying therapy

88 employees · est. 2014 · Miami, United States

VS
Zymeworks Inc. logo

Zymeworks Inc.

Developing novel medicines for patients with difficult-to-treat cancers and other serious diseases.

271 employees · est. 2003 · Canada

Zymeworks Inc. is the older company (2014 vs 2003); Zymeworks Inc. is the larger of the two.

Side-by-Side Comparison

SAB BIO Zymeworks Inc.
Founded
2014 2003 older
Headquarters
Miami, United States Canada
Employees
88 271 larger
Industry
Biotechnology, Health and Wellness Biotechnology, Health and Wellness
Funding Stage
Post Ipo Equity IPO
Total Funding
$186.32M $867.80M
Funding Rounds
7 17
Services
Not tracked yet Development of novel medicines, Management of healthcare assets, Partnership integration, Proprietary platform utilization
Target Customers
Not tracked yet Patients with difficult-to-treat diseases, Healthcare providers, Pharmaceutical partners, Biotechnology researchers
Taxonomy
Biopharmaceuticals, Immunotherapy, Type 1 Diabetes, Clinical-stage, Disease-modifying, Antibody Therapeutics, Immunoglobulins, Antibody Science, Immunology, Autoimmune Diseases, Public Health, Rare Conditions, Long-term Diseases, Pandemic Threats Biotherapeutics, Antibody Engineering, Multispecific Antibodies, Antibody-drug Conjugates, Cancer Treatment, Autoimmune Diseases, Inflammatory Diseases, Protein Therapeutics, Molecular Modeling, In Silico Experimentation, Protein Optimization, Biologics Drug Discovery, Next-generation Antibody Therapeutics, Computational Biotechnology
Website
sab.bio zymeworks.com
SAB BIO logo

About SAB BIO

SAb Biotherapeutics is a biotechnology startup founded in 2014 and headquartered in the United States. The company is dedicated to developing a disease-modifying immunotherapy aimed at delaying the onset and progression of type 1 diabetes. They have a novel immunotherapy platform focused on developi...

Zymeworks Inc. logo

About Zymeworks Inc.

Zymeworks Inc., with its slogan "Developing novel medicines for patients with difficult-to-treat cancers and other serious diseases,” is a pioneering player in the biotechnology and health and wellness industries. Founded in 2003 and headquartered in Canada, the company is focused on advancing a por...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at SAB BIO and Zymeworks Inc. — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at SAB BIO and Zymeworks Inc. — by email.

Frequently Asked Questions

SAB BIO — Working to transform treatment for people living with type 1 diabetes through a unique disease-modifying therapy. Zymeworks Inc. — Developing novel medicines for patients with difficult-to-treat cancers and other serious diseases.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
SAB BIO has raised $186.32M while Zymeworks Inc. has raised $867.80M.
SAB BIO and Zymeworks Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare SAB BIO with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy